Speaker

Michael Jacobson

CEO & CSO, Alnivo Therapeutics

Michael Jacobson, CEO & CSO at Alnivo Therapeutics, is speaking at 10th Dermatology Drug Development Summit (Boston, United States of America, 3–5 Nov 2026) in the session “Panel Discussion: Bringing Cosmetic Dermatology Back into R&D & Addressing High Patient Demand Through Scientific Innovation”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

10th Dermatology Drug Development Summit
3–5 Nov 2026Boston, United States of America
- PanelPanel Discussion: Bringing Cosmetic Dermatology Back into R&D & Addressing High Patient Demand Through Scientific InnovationWith Frederick Beddingfield, Lotus Mallbris

More speakers at 10th Dermatology Drug Development Summit

Mudgal Kothekar
Vice President Clinical Development, Sun Pharma Advanced Research Company Ltd.
Maria Akerman
Director, Global Programs, Affibody AB
John Armstrong
Head of Healthcare Banking, Westpark Capital
Dan Brownell
Senior Director, AOBiome
Kenneth Crook
Head of Translational Medicine, Engimmune Therapeutics
Suryasarathi Dasgupta
Director - Scientific & Precision Medicine Immunology, Abbvie

See all 30 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Michael Jacobson, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].